LOS ANGELES, May 31, 2005 (PRIMEZONE) -- HomelandInsights.com, the online source for expert information on high-growth investing in the multi-billion dollar Homeland Security marketplace, has announced the availability of an interview with Boris Rubizhevsky, President of the Homeland Security division of Isonics Corporation, (Nasdaq:ISON).
Isonics, committed to the development of next-generation technology for the homeland security and semiconductor markets, is a technology innovator developing a number of proprietary technologies and services for the global homeland security sector.
In the interview, Mr. Rubizhevsky discusses Isonics' strategy for the creation of a multi-dimensional Homeland Security division through acquisitions of complementary technologies and cash-positive companies. Among the topics covered is the recent Isonics acquisition of Protection Plus Security Consultants. He also discusses the intended acquisition of IUT-Berlin, the Company's longtime technology development partner on the NeutroTest(tm) explosive detection device and other initiatives.
The interview is available free of charge to interested investors. To listen to the interview, visit http://www.HomelandInsights.com.
About Isonics Corporation
Isonics Corporation has three business divisions: (1) Isonics Semiconductor, (2) Isonics Life Sciences, and (3) Homeland Security and Defense. Isonics is a world leader in isotopically engineered materials and through its semiconductor division produces isotopically pure silicon-28 chemicals and wafers for the semiconductor industry. Isonics' Life Sciences division markets and sells isotopes to the health care industry for the imaging and treatment of cancer. Stable isotopes can be thought of as ultra pure materials. This high degree of purification provides enhanced properties as compared to natural materials. Our efforts in the Homeland Security segment are nascent at the present time as we proceed to develop further our neutron-based detection technologies. Additional information may be obtained at the Company's Web site at http://www.trilogy-capital.com/tcp/isonics. A presentation about Isonics' NeutroTest(tm) explosive detection prototype can be found at http://www.trilogy-capital.com/tcp/isonics/presentation.html. A video demonstrating the functioning NeutroTest prototype can be viewed at http://www.trilogy-capital.com/tcp/isonics/video.html.
About HomelandInsights.com
HomelandInsights.com provides exclusive commentary, research, interviews and other information focused on the fast-growing global homeland security marketplace. The primary mission of HomelandInsights.com is to provide informed investors with information and commentary about investment growth opportunities within the homeland security industry. Resources available on HomelandInsights.com include audio interviews with corporate leaders and respected commentators, as well as technical white papers and other forms of market and investment analysis. It is located at http://www.HomelandInsights.com.
Compensation and Other Disclosures
HomelandInsights.com is a wholly-owned subsidiary of Trilogy Capital Partners, Inc. Trilogy Capital Partners provides investor relations services to public companies. The companies presented by HomelandInsights.com are usually clients of Trilogy Capital Partners and compensate Trilogy Capital Partners for these services, including cash compensation and equity securities. In addition, Trilogy Capital Partners and its affiliates may own securities of the presenting companies, and may from time to time purchase and sell securities of these companies in the open market or in private transactions. Isonics Corporation pays Trilogy an aggregate of $125,000 for the period April through September 2005. In addition, as of May 23, 2005, a subsidiary of Trilogy has warrants to purchase from a non-affiliate shareholder of this company 100,000 shares of common stock for $1.35 per share.
Cautionary Statement
Except for historical information contained herein, this document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Further, the Company operates in industries where securities values may be volatile and may be influenced by regulatory and other factors beyond the Company's control. Other important factors that the Company believes might cause such differences are discussed in the risk factors detailed in the Company's 10-KSB for the year ended April 30, 2004, its quarterly report on Form 10-QSB for the nine months ended January 31, 2005, and other documents filed with the Securities and Exchange Commission, which include the Company's historical cash flow difficulties, dependence on significant customers, and rapid development of technology, among other risks. In assessing forward-looking statements contained herein, readers are urged to carefully read all cautionary statements contained in the Company's filings with the Securities and Exchange Commission. Isonics cautions investors that there are currently no commercial NeutroTest products, and no guarantee there will be. Isonics has made no NeutroTest sales and no government agency or other person has expressed an interest in purchasing NeutroTest. There can be no assurance that Isonics will be able to manufacture the NeutroTest for the market at a cost and with capabilities that meet the needs of prospective customers.
This announcement may contain forward-looking statements made by senior management of Isonics that involve risks and uncertainties, such as statements about plans, objectives, expectations, assumptions or future events. These statements involve estimates, assumptions, known and unknown risks, uncertainties and performances, or achievements expressed or implied by the forward-looking statements. Actual future results and trends may differ materially from those made in -- or suggested by -- statements made in this announcement due to a variety of factors. Consequently, you should not place undue reliance on any forward-looking statements made in this announcement. For more information about Isonics and risks arising from investing in Isonics, you are directed to the Company's most recent Form 10-KSB filed with the Securities and Exchange Commission.